3 completed, 1 withdrawn. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Withdrawn 1 |
Follow Sickle Cell Anemia: new trials by email Literature Review of Sickle Cell Anemia trials Research Report on Sickle Cell Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Actigraphy Improvement With Voxelotor (ActIVe) Study Voxelotor - Sickle Cell Disease, Sickle Cell Anemia | Phase 4 | Completed | Pfizer | 25 | 2020-12-21 | 2023-11-21 |
| Voxelotor Sickle Cell Exercise Study Voxelotor - Sickle Cell Anemia | Phase 4 | Completed | Elizabeth Yang, MD, PhD | 14 | 2020-09-21 | 2022-06-15 |
| Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment hydroxyurea - Sickle Cell Disease, Sickle Cell Anemia | Phase 4 | Completed | Loyola University | 53 | 2014-12-01 | 2023-03-09 |
| Endothelial Function in Patients With Sickle Cell Anemia Before and After Sildenafil Viagra (Sildenafil), placebo - Sickle Cell Anemia | Phase 4 | Withdrawn | The Baruch Padeh Medical Center, Poriya | 15 | 2009-09-01 | 2010-03-02 |
Anemia (4) · Anemia, Hemolytic (4) · Anemia, Hemolytic, Congenital (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Hemoglobinopathies (4)
voxelotor (2) · Hydroxyurea (1) · Sildenafil Citrate (1)
Elizabeth Yang, MD, PhD (1) · Loyola University (1) · Pfizer (1) · The Baruch Padeh Medical Center, Poriya (1)
United States (2) · Israel (1) · Nigeria (1)
Bamidele O Tayo, PhD (1) · Elizabeth Yang, MD, PhD. (1) · Kari Wheeler, BSN, RN (1) · Lewis Hsu, MD (1) · Richard S Cooper, MD (1) · Titilola S Akingbola, MBBS, FWACP (1) · Victor R Gordeuk, MD (1) · Vivian Phan, MS (1)